RE:RE:NASDAQ ListingAs I've made clear enough, I'm generally sceptical of moves that are aimed more at marketing the stock as opposed to marketing the products and services the company offers to customers. My experience tells me that if you demonstrate a great investment story then investors will find their way to it, regardless of where it's listed, etc.
I suppose this might be an issue if the stock were only listed in, say, Tajikistan, though even then that would likely be more a host-country-specific issue than a company-specific issue.
Quarterhill might want to someday return to $US reporting but I think they could do that without any formal US listing.
Also, US investors can always just buy QTRHF. I've bought many shares that way.
If the company really wants to go down the expensive and complicated route of formally re-listing in the US, they should, at the very least, do (or find / access) some kind of study relating to how much it has actually proved to be worth it in terms of higher market valuations.
While I admit that my impression is that US valuations probably do tend to be higher relative to underlying values, I can also think of some counterexamples.
Right now Nuvei (NVEI) is a red-hot Canadian stock that has no US listing. Stock has gone from $50 to $160 in 10 months. It gets tons of chatter on Reddit.
I don't know if they're planning to get a US listing. Their exposure and underlying business appear to be doing fine without it.
Would their share price be higher if they had a US listing? I doubt it. As I say, it's already getting tons of attention in the US.
Note also that Nuvei, even with their lack of a US listing, is already being covered by many top analysts outside Canada. They are currently covered by analysts from:
Credit Suisse
Citigroup
Cowen & Co.
Goldman Sachs
(and possibly more that I don't know about)
What a US listing MIGHT do is simply make the stock more volatile. I'm not sure that would be such a great thing.
Regardless--and this is my main point here--if there is to be a decision on a re-listing in the US, it should be made on the basis of actual data and not just some kind of (possibly-outdated) pro-US-listing folk wisdom.